Inhibita is a 40 mg capsule from Delta Pharma Limited that contains omeprazole, a proton pump inhibitor. It reduces the amount of acid the stomach produces and is used in several acid-related conditions.
There are 120 brands of Omeprazole listed in Bangladesh. 50 of them have a lower unit price than Inhibita. The lowest listed price is Re 40 mg Capsule at ৳ 1 per unit.
What is Inhibita 40 mg Capsule?
Inhibita 40 mg Capsule is a proton pump inhibitor. Its active ingredient is omeprazole, which works by blocking the enzyme system in the stomach that produces acid. Because it lowers acid secretion, it is used in conditions where stomach acid causes or worsens symptoms. The capsule comes from Delta Pharma Limited. Omeprazole is also prescribed for people who need protection against ulcers linked to certain pain medicines. How long you take it, and at what dose, is set by your doctor after assessing your condition.
Uses of Inhibita
Inhibita is used for gastric and duodenal ulcers, including ulcers associated with NSAID pain medicines, and to help prevent such ulcers in people with a history of them. It is also used for gastro-esophageal reflux disease, long-term management of acid reflux, acid-related dyspepsia and severe ulcerating reflux esophagitis. Your doctor will confirm whether it suits your condition.
How to use Inhibita
Inhibita is taken by mouth as a capsule. The dose and how long you take it depend on your condition and are decided by your doctor, so follow the instructions given to you. Do not change the dose or stop early on your own. If you miss a dose or are unsure about anything, ask your doctor or pharmacist for guidance rather than adjusting it yourself.
Side effects of Inhibita
Omeprazole is generally well tolerated. Some people may experience nausea, abdominal colic, tingling sensations, dizziness or headache. These are usually mild and short-lived and do not normally require a change in dose. If any effect bothers you, persists or seems unusual, speak to your doctor or pharmacist so it can be assessed.
Safety and precautions
Do not take Inhibita if you are allergic to omeprazole or any other ingredient of the capsule. Before starting treatment, tell your doctor if a gastric ulcer is suspected, because the possibility of gastric malignancy needs to be excluded first; treatment can ease symptoms and delay diagnosis. Omeprazole has a US FDA pregnancy category C, and breastfeeding may need to be stopped if its use is essential, so pregnant or breastfeeding women should ask their doctor first. Also mention other medicines you take, as omeprazole can affect how some drugs, such as warfarin, phenytoin and diazepam, are cleared from the body.
Frequently asked questions
What is Inhibita used for and what kind of medicine is it?
Inhibita is a proton pump inhibitor containing omeprazole. It is used for gastric and duodenal ulcers, NSAID-associated ulcers and their prevention, gastro-esophageal reflux disease, long-term acid reflux management, acid-related dyspepsia and severe ulcerating reflux esophagitis.
How should Inhibita be taken?
Inhibita is a capsule taken by mouth. Your doctor decides the dose and how long the course should last, based on your condition. Follow those instructions and do not change the dose yourself. Ask your doctor or pharmacist if anything is unclear.
Who should avoid Inhibita or ask the doctor first?
Anyone allergic to omeprazole or the capsule's other ingredients should not take it. People with suspected gastric ulcer, pregnant or breastfeeding women, and those taking other medicines such as warfarin, phenytoin or diazepam should speak to their doctor before use.
As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
... Read more
Omeprazole is indicated for the treatment of-
Gastric and duodenal ulcer
NSAID-associated duodenal and gastric ulcer
As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
Acid-related dyspepsia
Severe ulcerating reflux esophagitis
Prophylaxis of acid aspiration during general anesthesia
Zollinger-Ellison syndrome
Helicobacter pylori-induced peptic ulcer.
Pharmacology
Omeprazole, a substituted benzimidazole, is an inhibitor of gastric acid secretion. It inhibits gastric acid secretion by blocking hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell. After oral administration, the onset of the antisecretory effect occurs within one hour, with the maximum effect occurring within two hours and inhibition of secretion lasts up to 72 hours. When the drug is discontinued, secretory activity returns gradually, over 3 to 5 days.
Dosage & Administration
Oral-
Benign gastric and duodenal ulcer: 20 mg once daily for 4 weeks in duodenal ulceration, 8 weeks in gastric ulceration; in severe or recurrent cases, dose to be increased to 40 mg daily; maintenance dose for recurrent duodenal ulcer, 20 mg once daily; in prevention of relapse in duodenal ulcer, 10-20 mg daily.
NSAID-associated duodenal or gastric ulcer: 20 mg once daily for 4 weeks, continued for further 4 weeks, if not fully healed. 20 mg once daily is used as prophylaxis in patients with a history of NSAID-associated duodenal or gastric ulcers.
Gastro-esophageal reflux disease: 20 mg once daily for 4 weeks, continued for further 4-8 weeks, if not fully healed; 40 mg once daily has been given for 8 weeks in gastro-esophageal reflux disease, refractory to other treatment; maintenance dose is 20 mg once daily.
Long-term management of acid reflux disease: 10-20 mg daily.
Acid-related dyspepsia: 10-20 mg once daily for 2-4 weeks.
Prophylaxis of acid aspiration: 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery.
Zollinger-Ellison syndrome: Initially 60 mg once daily; usual range 20-120 mg daily (If daily dose is more than 80 mg, 2 divided dose should be used).
Helicobacter pylori eradication regimen in peptic ulcer disease: Omeprazole is recommended at a dose of 20 mg twice daily in association with antimicrobial agents as detailed below: Amoxicillin 500 mg and Metronidazole 400 mg both three times a day for one week, or Clarithromycin 250 mg and Metronidazole 400 mg both twice a day for one week, or Amoxicillin 1 g and Clarithromycin 500 mg both twice a day for one week.
Paeditaric use in severe ulcerating reflux esophagitis (Child>1 year): If body-weight 10-20 kg, 10-20 -mg once daily for 4-12 weeks; if body-weight over 20 kg, 20-40 mg once daily for 4-12 weeks.
IV Injection-
Prophylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.
Duodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.
Zollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.
Interaction
Omeprazole can prolong the elimination of diazepam, warfarin and phenytoin. So, reduction of warfarin or phenytoin dose may be necessary when Omeprazole is added to the treatment. There is no evidence of an interaction of Omeprazole with theophylline, propranolol or antacids.
Contraindications
Omeprazole is contraindicated in patients with known hypersensitivity to any of the components of the formulation.
Side Effects
Omeprazole is generally well tolerated. Nausea, abdominal colic, paresthesia, dizziness and headache have been stated to be generally mild and transient and not requiring a reduction in dosage.
Pregnancy & Lactation
US FDA pregnancy category of Omeprazole is C. However, results from three prospective epidemiological studies indicate no adverse effects of Omeprazole on pregnancy or on the health of the fetus/newborn child. There is no information available on the passage of Omeprazole into breast milk or its effects on the neonate. Breast-feeding should, therefore, be discontinued, if the use of Omeprazole is considered essential.
Precautions & Warnings
When gastric ulcer is suspected, the possibility of gastric malignancy should be excluded before treatment with Omeprazole is instituted, as treatment may alleviate the symptoms and delay diagnosis.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
Alternative brands of Omeprazole
Other brands with the same generic name, cheapest first.